Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 1:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 1,719 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Positive Control Clear all

Conditions: Healthy
Interventions: ODV Placebo (Matching 25 mg ODV), ODV Placebo (Matching 200 mg ODV), ODV Placebo (Matching 125 mg ODV), ODV Placebo (Matching 100 mg ODV), SMV Placebo (Matching 150 mg SMV), AL-335 Placebo (matching 1200 mg AL-335), Moxifloxacin Placebo (matching 400 mg moxifloxacin), ODV 25 mg, ODV 200 mg, ODV 125 mg, ODV 100 mg, SMV 150 mg, AL-335 1200 mg; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Mastectomy, Gender Affirmation Surgery, Nipple Sparing Mastectomy, Prophylactic Mastectomy, Benign Breast Condition
Interventions: AmnioFix dehydrated Human Amnion/Chorion Membrane Allograft, Control Device; Device
Lead sponsor: Stanford University; Other
Eligibility: 15 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Alcohol Dependence, Alcohol Abuse
Interventions: Motivational Interviewing, Spirit-Only Motivational Interviewing, Self-Change; Behavioral · Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Pain, Postoperative, Fracture, Ankle, Pilon Fracture of Tibia, Foot Fracture
Interventions: Auricular acupuncture; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Congenital Syphilis
Interventions: Congenital Syphilis Intervention Group; Behavioral
Lead sponsor: Tulane University School of Public Health and Tropical Medicine; Other
Eligibility: 13 Years and older · Female only
Enrollment: 60,386 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Coronary Artery Disease
Interventions: Ga-68 Galmydar, 13N-ammonia; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 99 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Mental Health Issue
Interventions: Weyera Intervention, Delayed intervention (waitlist control); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Atlanta, Georgia • Clarkston, Georgia • Stone Mountain, Georgia

Conditions: Child Behavior Problems
Interventions: Immediate CARE; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Valacyclovir, Placebo; Drug
Lead sponsor: Konasale Prasad; Other
Eligibility: 18 Years to 50 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 2
States / cities: Detroit, Michigan • Pittsburgh, Pennsylvania

Conditions: Sickle Cell Anemia, Acute Chest Syndrome
Interventions: Bi-level positive airway pressure device, Sham CPAP; Device
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 4 Years to 21 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Hypoplastic Left Heart Syndrome
Interventions: c-kit+ cells; Biological
Lead sponsor: Joshua M Hare; Other
Eligibility: 1 Day to 21 Days
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 4
States / cities: Atlanta, Georgia • Chicago, Illinois • Baltimore, Maryland + 1 more

Conditions: Tobacco Use
Interventions: Approach Avoidance Training, SHAM Training; Other
Lead sponsor: Jasper A. Smits; Other
Eligibility: 18 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Any Cancer Diagnosis
Interventions: Play Intervention, Questionnaires; Behavioral · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 4 Years to 10 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Type 1 Diabetes Mellitus
Interventions: MPC control algorithm, PID control algorithm; Device
Lead sponsor: Sansum Diabetes Research Institute; Other
Eligibility: 21 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Type 2 Diabetes Mellitus
Interventions: Proteus Sustained Behavior Change system, Regularly prescribed diabetes medicines (metformin, sulfonylureas, thiazolidinediones, DPP-IV inhibitors, alpha-glucosidase inhibitors); Device · Drug
Lead sponsor: Proteus Digital Health, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: liraglutide, placebo, moxifloxacin, electrocardiogram (ECG); Drug · Procedure
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Major Depression, Dysthymia, Depressive Symptoms
Interventions: Teen Depression Module used for care; Behavioral
Lead sponsor: Total Child Health, Inc.; Industry
Eligibility: 12 Years to 99 Years
Enrollment: 580 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cardiodynamics, Safety, Tolerability, Pharmacokinetics
Interventions: selexipag, placebo for selexipag, moxifloxacin, moxifloxacin-matching placebo; Drug
Lead sponsor: Actelion; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Breast Cancer Metastatic
Interventions: Amcenestrant, Fulvestrant, Anastrozole, Letrozole, Exemestane, Tamoxifen; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 367 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 14
States / cities: Birmingham, Alabama • Bakersfield, California • Santa Monica, California + 11 more

Conditions: Healthy, Memory Impairment
Interventions: AZD8529, Placebo to match AZD8529; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 21 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Parents
Interventions: Familia Bora; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 792 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Acute Respiratory Failure
Interventions: External nasal dilator (END), High flow nasal cannula (HFNC); Device · Other
Lead sponsor: Loma Linda University; Other
Eligibility: 1 Day to 18 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Obesity, Childhood, Overweight, Childhood, Overnutrition, Pediatric Obesity, Eating, Healthy
Interventions: Associative Conditioning, Repeated Exposure; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 3 Years to 5 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Cannabis, Drug Effects, Driving Performance
Interventions: 5 mg Dronabinol (Marinol®) + Placebo Beverage, 10 mg Dronabinol (Marinol®) + Placebo Beverage, 5 mg Dronabinol (Marinol®) + Alcohol Beverage, 10 mg Dronabinol (Marinol®) + Alcohol Beverage, Placebo Capsule + Alcohol Beverage, Placebo Capsule + Placebo Beverage; Drug
Lead sponsor: Food and Drug Administration (FDA); Federal
Eligibility: 21 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: West Bend, Wisconsin

Search by objective public record fields.

A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants

The Role of Amnion Membrane Allografts in Nipple Preservation

Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking

Auricular Acupuncture as Part of Multimodal Analgesia After Lower Leg Fracture

Preventing Congenital Syphilis

Myocardial Perfusion Imaging Galmydar Rest/Stress

Weyera Mental Health Pilot Intervention

Parent Program to Improve Child Behavior Problems

Systematic Evaluation of Antiviral Medication in Schizophrenia

Bi-Level Positive Airway Ventilation for Acute Chest Syndrome

The CHILD Trial: Hypoplastic Left Heart Syndrome Study.

The Effect of AAT Training in Smokers

A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer

Feasibility Study of PID Versus MPC and HMS

Proteus Sustained Behavior Change Study

Effect of Liraglutide on Heart Frequency in Healthy Volunteers

Online System for Identifying and Addressing Teen Depression in Primary Care

Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

Father-Inclusive Parenting Intervention in Mwanza, Tanzania

External Nasal Dilator and Oxygen Therapy in Respiratory Failure

Promoting Food Acceptance Through Positive Parenting: the Play and Grow Study

Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults